Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.4 USD | +1.26% | +3.53% | +7.39% |
May. 17 | Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target | MT |
May. 17 | ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta... |
Financials (USD)
Sales 2024 * | 55.16B | Sales 2025 * | 58.06B | Capitalization | 294B |
---|---|---|---|---|---|
Net income 2024 * | 7.74B | Net income 2025 * | 10.64B | EV / Sales 2024 * | 6.32 x |
Net Debt 2024 * | 54.72B | Net Debt 2025 * | 47.3B | EV / Sales 2025 * | 5.88 x |
P/E ratio 2024 * |
32.3
x | P/E ratio 2025 * |
24.8
x | Employees | 50,000 |
Yield 2024 * |
3.72% | Yield 2025 * |
3.91% | Free-Float | 96.38% |
Latest transcript on AbbVie Inc.
1 day | +1.26% | ||
1 week | +3.53% | ||
Current month | +2.32% | ||
1 month | +1.32% | ||
3 months | -6.24% | ||
6 months | +20.33% | ||
Current year | +7.39% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | +8.97% | - | |
6.85% | 17 M€ | +7.73% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 166.4 | +1.26% | 5,152,176 |
24-05-16 | 164.4 | +0.34% | 4,642,038 |
24-05-15 | 163.8 | +1.36% | 5,261,263 |
24-05-14 | 161.6 | +0.19% | 4,025,032 |
24-05-13 | 161.3 | +0.33% | 3,505,882 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.39% | 294B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B | |
-0.52% | 162B |
- Stock Market
- Equities
- ABBV Stock